PubMed · 1981 · 10 citations · 0 references
Surgical OncologyPediatric Brain TumorsPediatric NhlPathologyMetronomic ChemotherapyMalignant LymphomasImmunotherapyNeuro-oncologyPediatric Non HodgkinPediatric EpidemiologySurgical PathologyMetronomic TherapyRadiation OncologyChemotherapyCancer ResearchRadiologyHealth SciencesLymphoid NeoplasiaCombination ChemotherapyRadiation TherapyMedicineNon HodgkinCancer TreatmentRadiologic ImagingPediatric HematologyMalignant Blood DisorderPediatricsOncology
178 children presenting with non Hodgkin's lymphomas (NHL) were treated using the same protocol from 1973 to 1978 at the Institut Gustave-Roussy. They were classified according to stages (13 stage I, 21 stage II, 80 stage III, 50 stage IV, 6 undetermined stage), according to initial site of involvement (abdomen: 68, mediastineum 55, ORL: 32, lymph glands: 13, "others": 10) and according to histology. They were given combination chemotherapy (Vincristinee-adriamycin-cyclophosphamide-prednisone), preventive CNS therapy by cranial irradiation and intrathecal methotrexate (except in stage I patients) and maintenance therapy by cyclic multiple agents regimens including vincristin-adriamycin, vincristin-cyclophosphamide and cytarabine-asparaginase. Radiation therapy was carried out up to 1977 in stage I and II patients only. Combination chemotherapy improved global survival of pediatric NHL (40% at 4 years, all staged added); however improvements remain to be done in patients with widespread disease.